A study in human cardiac stromal cells from arrhythmogenic cardiomyopathy (ACM) patients demonstrated that the mir-29b-2 was significantly upregulated in ACM cells compared to healthy controls, with its target genes enriched in extracellular matrix organization pathways [Rainer et al. DOI:10.1186/s12864-018-4876-6]. In human skin, the mir-29b-2 was found to be downregulated in deep partial-thickness burn skin five days post-injury and in differentiated myofibroblasts, indicating its role in burn response and fibrotic scarring [Siu et al. DOI:10.1111/wrr.13100]. A study in rhesus macaques demonstrated that the mir-29b-2 was utilized as a feature in a Day 15 pleural effusion prediction model stratified by gender [May et al. DOI:10.1038/s41598-022-16316-x].